HEADER TRANSFERASE/INHIBITOR 21-DEC-22 8FLG TITLE BRUTON'S TYROSINE KINASE IN COMPLEX WITH AN ORTHOSTERIC INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE BTK; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: AGAMMAGLOBULINEMIA TYROSINE KINASE,ATK,B-CELL PROGENITOR COMPND 5 KINASE,BPK,BRUTON TYROSINE KINASE; COMPND 6 EC: 2.7.10.2; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BTK, AGMX1, ATK, BPK; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS TYROSINE PROTEIN KINASE BTK, LIGASE, TRANSFERASE-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR C.M.METRICK,D.J.MARCOTTE REVDAT 1 01-MAR-23 8FLG 0 JRNL AUTH G.H.VANDEVEER,R.M.ARDUINI,D.P.BAKER,K.BARRY,T.BOHNERT, JRNL AUTH 2 J.K.BOWDEN-VERHOEK,P.CONLON,P.F.CULLEN,B.GUAN,T.J.JENKINS, JRNL AUTH 3 S.Y.LIAO,L.LIN,Y.T.LIU,D.MARCOTTE,E.MERTSCHING,C.M.METRICK, JRNL AUTH 4 E.NEGROU,N.POWELL,D.SCOTT,L.F.SILVIAN,B.T.HOPKINS JRNL TITL DISCOVERY OF STRUCTURAL DIVERSE REVERSIBLE BTK INHIBITORS JRNL TITL 2 UTILIZED TO DEVELOP A NOVEL IN VIVO CD69 AND CD86 PK/PD JRNL TITL 3 MOUSE MODEL. JRNL REF BIOORG.MED.CHEM.LETT. V. 80 29108 2023 JRNL REFN ESSN 1464-3405 JRNL PMID 36538993 JRNL DOI 10.1016/J.BMCL.2022.129108 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.20.1_4487 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 31.23 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 94.6 REMARK 3 NUMBER OF REFLECTIONS : 14213 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.198 REMARK 3 R VALUE (WORKING SET) : 0.195 REMARK 3 FREE R VALUE : 0.254 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.030 REMARK 3 FREE R VALUE TEST SET COUNT : 715 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 31.2300 - 3.7600 0.99 2949 173 0.1814 0.2156 REMARK 3 2 3.7600 - 2.9800 0.99 2855 134 0.1921 0.2481 REMARK 3 3 2.9800 - 2.6100 0.96 2749 123 0.2168 0.3161 REMARK 3 4 2.6100 - 2.3700 0.91 2512 158 0.2054 0.3053 REMARK 3 5 2.3700 - 2.2000 0.87 2433 127 0.2077 0.2630 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.258 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 24.513 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 24.08 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 25.66 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 2139 REMARK 3 ANGLE : 0.917 2901 REMARK 3 CHIRALITY : 0.052 312 REMARK 3 PLANARITY : 0.007 367 REMARK 3 DIHEDRAL : 16.575 772 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8FLG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 11-JAN-23. REMARK 100 THE DEPOSITION ID IS D_1000270943. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 06-APR-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E+ SUPERBRIGHT REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV++ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 14214 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.5 REMARK 200 DATA REDUNDANCY : 3.800 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 18.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.36 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.79 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.31 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: BIS-TRIS, AMMONIUM SALT, PEG, VAPOR REMARK 280 DIFFUSION, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 35.62050 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 52.12000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 35.62050 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 52.12000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 367 REMARK 465 PRO A 368 REMARK 465 LEU A 369 REMARK 465 GLY A 370 REMARK 465 SER A 371 REMARK 465 ARG A 372 REMARK 465 LEU A 373 REMARK 465 LYS A 374 REMARK 465 TYR A 375 REMARK 465 PRO A 376 REMARK 465 VAL A 377 REMARK 465 SER A 378 REMARK 465 GLN A 379 REMARK 465 GLN A 380 REMARK 465 ASN A 381 REMARK 465 LYS A 382 REMARK 465 ASN A 383 REMARK 465 ALA A 384 REMARK 465 PRO A 385 REMARK 465 SER A 386 REMARK 465 THR A 387 REMARK 465 ALA A 388 REMARK 465 GLY A 389 REMARK 465 LEU A 390 REMARK 465 GLY A 391 REMARK 465 TYR A 392 REMARK 465 GLY A 393 REMARK 465 SER A 394 REMARK 465 GLN A 412 REMARK 465 PHE A 413 REMARK 465 LYS A 466 REMARK 465 GLN A 467 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ILE A 397 CG1 CG2 CD1 REMARK 470 LEU A 405 CG CD1 CD2 REMARK 470 LYS A 406 CG CD CE NZ REMARK 470 LYS A 433 CD CE NZ REMARK 470 GLU A 434 CG CD OE1 OE2 REMARK 470 GLU A 444 CG CD OE1 OE2 REMARK 470 LYS A 447 CG CD CE NZ REMARK 470 VAL A 448 CG1 CG2 REMARK 470 SER A 453 OG REMARK 470 GLU A 455 CG CD OE1 OE2 REMARK 470 GLN A 459 CG CD OE1 NE2 REMARK 470 ARG A 468 CG CD NE CZ NH1 NH2 REMARK 470 GLN A 496 CG CD OE1 NE2 REMARK 470 GLN A 516 CG CD OE1 NE2 REMARK 470 GLU A 550 CG CD OE1 OE2 REMARK 470 THR A 552 OG1 CG2 REMARK 470 VAL A 555 CG1 CG2 REMARK 470 SER A 557 OG REMARK 470 LYS A 558 CG CD CE NZ REMARK 470 LYS A 595 CG CD CE NZ REMARK 470 ARG A 600 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 608 CG CD OE1 OE2 REMARK 470 GLU A 624 CG CD OE1 OE2 REMARK 470 LYS A 625 CG CD CE NZ REMARK 470 LYS A 637 CG CD CE NZ REMARK 470 ASP A 639 CG OD1 OD2 REMARK 470 LYS A 645 CG CD CE NZ REMARK 470 GLU A 658 CG CD OE1 OE2 REMARK 470 SER A 659 OG REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 ASP A 401 N CA C O CB CG OD1 REMARK 480 ASP A 401 OD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 520 -11.04 73.76 REMARK 500 ASP A 521 44.74 -145.74 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 911 DISTANCE = 8.38 ANGSTROMS DBREF 8FLG A 371 659 UNP Q06187 BTK_HUMAN 371 659 SEQADV 8FLG GLY A 367 UNP Q06187 EXPRESSION TAG SEQADV 8FLG PRO A 368 UNP Q06187 EXPRESSION TAG SEQADV 8FLG LEU A 369 UNP Q06187 EXPRESSION TAG SEQADV 8FLG GLY A 370 UNP Q06187 EXPRESSION TAG SEQRES 1 A 293 GLY PRO LEU GLY SER ARG LEU LYS TYR PRO VAL SER GLN SEQRES 2 A 293 GLN ASN LYS ASN ALA PRO SER THR ALA GLY LEU GLY TYR SEQRES 3 A 293 GLY SER TRP GLU ILE ASP PRO LYS ASP LEU THR PHE LEU SEQRES 4 A 293 LYS GLU LEU GLY THR GLY GLN PHE GLY VAL VAL LYS TYR SEQRES 5 A 293 GLY LYS TRP ARG GLY GLN TYR ASP VAL ALA ILE LYS MET SEQRES 6 A 293 ILE LYS GLU GLY SER MET SER GLU ASP GLU PHE ILE GLU SEQRES 7 A 293 GLU ALA LYS VAL MET MET ASN LEU SER HIS GLU LYS LEU SEQRES 8 A 293 VAL GLN LEU TYR GLY VAL CYS THR LYS GLN ARG PRO ILE SEQRES 9 A 293 PHE ILE ILE THR GLU TYR MET ALA ASN GLY CYS LEU LEU SEQRES 10 A 293 ASN TYR LEU ARG GLU MET ARG HIS ARG PHE GLN THR GLN SEQRES 11 A 293 GLN LEU LEU GLU MET CYS LYS ASP VAL CYS GLU ALA MET SEQRES 12 A 293 GLU TYR LEU GLU SER LYS GLN PHE LEU HIS ARG ASP LEU SEQRES 13 A 293 ALA ALA ARG ASN CYS LEU VAL ASN ASP GLN GLY VAL VAL SEQRES 14 A 293 LYS VAL SER ASP PHE GLY LEU SER ARG TYR VAL LEU ASP SEQRES 15 A 293 ASP GLU TYR THR SER SER VAL GLY SER LYS PHE PRO VAL SEQRES 16 A 293 ARG TRP SER PRO PRO GLU VAL LEU MET TYR SER LYS PHE SEQRES 17 A 293 SER SER LYS SER ASP ILE TRP ALA PHE GLY VAL LEU MET SEQRES 18 A 293 TRP GLU ILE TYR SER LEU GLY LYS MET PRO TYR GLU ARG SEQRES 19 A 293 PHE THR ASN SER GLU THR ALA GLU HIS ILE ALA GLN GLY SEQRES 20 A 293 LEU ARG LEU TYR ARG PRO HIS LEU ALA SER GLU LYS VAL SEQRES 21 A 293 TYR THR ILE MET TYR SER CYS TRP HIS GLU LYS ALA ASP SEQRES 22 A 293 GLU ARG PRO THR PHE LYS ILE LEU LEU SER ASN ILE LEU SEQRES 23 A 293 ASP VAL MET ASP GLU GLU SER HET DMS A 701 4 HET Y8C A 702 27 HETNAM DMS DIMETHYL SULFOXIDE HETNAM Y8C N~2~-(3-CHLOROPHENYL)-N-[(3R)-1-(7H-PYRROLO[2,3- HETNAM 2 Y8C D]PYRIMIDIN-4-YL)PIPERIDIN-3-YL]GLYCINAMIDE FORMUL 2 DMS C2 H6 O S FORMUL 3 Y8C C19 H21 CL N6 O FORMUL 4 HOH *111(H2 O) HELIX 1 AA1 ASP A 398 LYS A 400 5 3 HELIX 2 AA2 SER A 438 MET A 450 1 13 HELIX 3 AA3 CYS A 481 ARG A 487 1 7 HELIX 4 AA4 GLU A 488 ARG A 492 5 5 HELIX 5 AA5 GLN A 494 LYS A 515 1 22 HELIX 6 AA6 ALA A 523 ARG A 525 5 3 HELIX 7 AA7 GLY A 541 VAL A 546 5 6 HELIX 8 AA8 ASP A 548 SER A 553 1 6 HELIX 9 AA9 PRO A 560 SER A 564 5 5 HELIX 10 AB1 PRO A 565 SER A 572 1 8 HELIX 11 AB2 SER A 575 SER A 592 1 18 HELIX 12 AB3 THR A 602 GLN A 612 1 11 HELIX 13 AB4 SER A 623 CYS A 633 1 11 HELIX 14 AB5 LYS A 637 ARG A 641 5 5 HELIX 15 AB6 THR A 643 SER A 659 1 17 SHEET 1 AA1 5 LEU A 402 GLY A 409 0 SHEET 2 AA1 5 VAL A 415 TRP A 421 -1 O TYR A 418 N LYS A 406 SHEET 3 AA1 5 TYR A 425 MET A 431 -1 O MET A 431 N VAL A 415 SHEET 4 AA1 5 PHE A 471 THR A 474 -1 O ILE A 472 N LYS A 430 SHEET 5 AA1 5 LEU A 460 CYS A 464 -1 N GLY A 462 O ILE A 473 SHEET 1 AA2 2 CYS A 527 VAL A 529 0 SHEET 2 AA2 2 VAL A 535 VAL A 537 -1 O LYS A 536 N LEU A 528 CISPEP 1 ARG A 468 PRO A 469 0 0.93 CRYST1 71.241 104.240 38.018 90.00 90.00 90.00 P 21 21 2 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014037 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009593 0.000000 0.00000 SCALE3 0.000000 0.000000 0.026303 0.00000